BPA Call 75F40119A10019-75F40123F19030

Award Date 5/1/23
Potential Completion Date 4/30/25
Potential Value $1.2M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $989,937.11 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) for data standards support services. The contract is a call order under the Regulatory Review Support Services Blanket Purchase Agreement. IBM will provide data standards and submission services to support the FDA's regulatory review processes. The contract does not have a set-aside designation. IBM is leveraging several subcontractors,...
This is a firm fixed price contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to International Business Machines Corporation (IBM) for $920,775.08. The contract, which is a Blanket Purchase Agreement (BPA) call, is for "REAL WORLD DATA - DATA STANDARDS FOR SUBMISSION TO FDA". IBM has utilized two subcontractors, Pinnacle 21, LLC and Gevity Consulting Inc., to provide computer programming services in...
This federal contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to International Business Machines Corporation (IBM) to provide "DATA STANDARDS TESTING AND IMPLEMENTATION FOR CDER." The $1,456,694.21 contract is a Blanket Purchase Agreement (BPA) Call awarded on September 8, 2021 with a completion date of March 28, 2025. IBM is leveraging minority-owned and small disadvantaged businesses, including...
This $691,911.16 firm fixed-price contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to provide support for data quality services. The contract is a call against IBM's Regulatory Review Support Services Blanket Purchase Agreement (BPA) with the FDA. The contract covers subject matter expertise for the development of data quality checks for incoming study data submissions. There is no set-aside designation for this award. IBM is the...
This federal contract award, with an ID of 75F40119A10019|75F40122F19025, was issued by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for $607,298.49 and was awarded to International Business Machines Corporation (IBM) to provide "ANALYSIS DATA STANDARDS SUPPORT DIGITAL HEALTH TECHNOLOGIES". It is a firm fixed price BPA call under IBM's existing Regulatory Review Support Services contract vehicle....
This is a $355,174.80 Blanket Purchase Agreement (BPA) call contract awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) for data standards testing and implementation services. The contract has no set-aside designation. IBM has been tasked with providing services to maintain and enhance the FDA's critical data systems used for clinical trial data validation and analysis. As a subcontractor, IBM has engaged Pinnacle 21, LLC and Eclaro...
This is a $8,547,961.83 firm fixed price contract awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to provide data management and analysis support for the OCS Clinical Services program. The contract was established as a Blanket Purchase Agreement (BPA) call under a larger Regulatory Review Support Services BPA. IBM will serve as the prime contractor, with subcontractor support from Pinnacle 21, LLC to provide computer programming services....
This federal contract award is for DATA STANDARDS TESTING AND IMPLEMENTATION services, with a ceiling value of $2,737,337.22. The contract was awarded to the prime contractor, International Business Machines Corporation (IBM), by the Food and Drug Administration (FDA), a civilian agency. The contract does not have a set-aside designation. The contract is a BPA (Blanket Purchase Agreement) call under the Regulatory Review Support Services master BPA. This indicates that the services being...
This is a $1,939,081.17 Regulatory Review Support Services contract awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) on September 26, 2020. The contract does not have a set-aside designation. IBM, a major federal contractor, will provide regulatory review support services to the FDA. The contract is a Blanket Purchase Agreement (BPA) call, with a total ceiling value of $1,939,081.17 and a completion date of September 29, 2025. As a...
This federal contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) for DATA MODERNIZATION PHASE 2 services. The $16,665,207.47 contract is a Blanket Purchase Agreement (BPA) call under the Regulatory Review Support Services master BPA. The contract is not set aside for any specific business designation. IBM, a large for-profit technology company, will provide labor hour-based IT services to modernize the FDA's data systems. The...

This $1,199,686.95 firm fixed price contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to provide ANALYSIS DATA STANDARDS SUPPORT for DIGITAL HEALTH TECHNOLOGIES under a Blanket Purchase Agreement (BPA) for Regulatory Review Support Services. The contract has a period of performance through April 30, 2025.

IBM will be supported by two subcontractors, Callideo, Inc. and Pinnacle 21, LLC, who will provide computer programmer services. Callideo is a minority-owned small disadvantaged business, while Pinnacle 21 specializes in software and services for managing CDISC compliance, clinical data quality, and FDA submission readiness. This contract does not utilize any set-aside designations.

Generated 4/13/25, 12:46 AM